News
-
Civitas Therapeutics has announced positive results from a Phase 1 clinical study of its CVT-301 inhaled dry powder formulation of levodopa (L-dopa) for the treatment of Parkinson’s disease. According to the company, the study showed… Read more . . .
-
ISTA Pharmaceuticals says that it has initiated a Phase 2 study of its Beposone bepotastine besilate/steroid combination nasal spray for the treatment of seasonal allergic rhinitis. Approximately 600 patients with allergic rhinitis caused by mountain… Read more . . .
-
The European Patent Office has granted patent number EP 2315580 B1 to Massachusetts biotech company Pulmatrix for “Pharmaceutical formulations and methods for treating respiratory tract infections.” The patent covers “both dry powder and liquid formulations… Read more . . .
-
California-based Elevation Pharmaceuticals has announced closing of $30 million in Series B financing for development of its lead product, EP-101, a glycopyrrolate inhalation solution for the treatment of COPD. Novo Ventures, a new investor, led… Read more . . .
-
Submit 2-3 page abstracts for oral or poster presentations by February 3, 2012 to admin@aerosol-soc.org.uk. Read more . . .
-
Drug Delivery & Formulation: Novel Technologies. Submit proposals for talks to Read more . . .
-
Wishing you a . . . Read more. Read more . . .
-
UK dry powder dispensing company VaryDose has announced the appointment of Philippe Rogueda as its Chief Technology Officer. According to the company, “Philippe brings with him many years’ experience and expertise in the powder handling… Read more . . .
-
Pharmaxis has announced that it “filed a minor resubmission with the Pharmaceutical Benefits Advisory Committee (PBAC)” for its Bronchitol mannitol dry powder inhaler for the treatment of cystic fibrosis. According to the company, the committee’s… Read more . . .
-
A Global Multinational Company headquartered in Italy, is seeking a target oriented, self-motivated individual who would be interested in working as Analytical Senior Scientist. Key Responsibilities: • Development and Validation of Drug Substance (DS) &… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.